Hairy-Cell Leukemia
New England Journal of Medicine · 10.10.2024 · 391 (14) · 1328-1341
DOI: 10.1056/nejmra2406376 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von Brunangelo Falini und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Institute of Hematology and the Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia,…. Hauptthemen laut MEDLINE: Leukemia, Hairy Cell, Watchful Waiting, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 106 Literaturangaben.
Abstract (Originalsprache)
Hairy-cell leukemia, a rare B-cell cancer driven by a BRAF mutation and manifesting with cytopenias and splenomegaly, is responsive to purine analogue chemotherapy and to BRAF inhibitors combined with anti-CD20 antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From the Institute of Hematology and the Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
Zitieren
APA
Falini, B., & Tiacci, E. (2024). Hairy-Cell Leukemia. New England Journal of Medicine, 391(14), 1328-1341. https://doi.org/10.1056/nejmra2406376
Vancouver
Falini B, Tiacci E. Hairy-Cell Leukemia. New England Journal of Medicine. 2024;391(14):1328-1341. doi:10.1056/nejmra2406376
BibTeX
@article{Falini2024,
author = {Falini, Brunangelo and Tiacci, Enrico},
title = {Hairy-Cell Leukemia},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {14},
pages = {1328--1341},
doi = {10.1056/nejmra2406376}
}
EUVIMED